- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0034198

Johnwin and Naq Biotechnologies Private Limited
About Johnwin and Naq Biotechnologies Private Limited
Data last updated:
Johnwin and Naq Biotechnologies Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the agricultural support services segment of the agriculture sector. It was incorporated on 11 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2013PTC257598.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shazia Afzal and Showkat Ahmad Naqash.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 283 Second Floor Vardhman Crown Mall Plot No.2 Sector – 19 Dwarka, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2020, the company reported a revenue of ₹9.2 Lakh. For the same year it recorded a net profit of ₹21,150 (net margin 2.3%) and EBITDA of ₹21,150 (EBITDA margin 2.3%).
Johnwin and Naq Biotechnologies Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0034198). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Johnwin and Naq Biotechnologies
Contact details
Johnwin and Naq Biotechnologies Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 283 Second Floor Vardhman Crown Mall Plot No.2 Sector – 19 Dwarka, New Delhi, Delhi, India – 110075
- IndustryAgriculture, Agricultural Support Services, Hunting
To see the full contact details of Johnwin and Naq Biotechnologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Johnwin and Naq Biotechnologies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Johnwin and Naq Biotechnologies Private Limited, buy the company report.
Financials of Johnwin and Naq Biotechnologies Private Limited
FY 2025 filings availableJohnwin and Naq Biotechnologies Private Limited reported revenue of ₹9.2 Lakh for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹9.2 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21,150 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21,150 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Johnwin and Naq Biotechnologies Private Limited, buy the company report.
Board of directors of Johnwin and Naq Biotechnologies Private Limited
Johnwin and Naq Biotechnologies has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shazia Afzal | Director | 12 Jun 2019 | 7 Years 4 Months | Current |
| Showkat Ahmad Naqash | Director | 11 Sep 2013 | 13 Years 1 Months | Current |
Shareholding
The shareholding of Johnwin and Naq Biotechnologies Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Johnwin and Naq Biotechnologies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Johnwin and Naq Biotechnologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Johnwin and Naq Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Johnwin and Naq Biotechnologies Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Johnwin and Naq Biotechnologies Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Shazia Afzal was appointed as Director on 12 Jun 2019.
Frequently asked questions
Johnwin and Naq Biotechnologies is an active private limited company based in New Delhi, Delhi, India. The company works in agricultural support services, within the agriculture industry. It was incorporated on 11 September 2013 (13+ years old) and is registered under CIN U85100DL2013PTC257598.
Johnwin and Naq Biotechnologies has 2 current directors:
- Shazia Afzal - Director
- Showkat Ahmad Naqash - Director
The latest financial statements of Johnwin and Naq Biotechnologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Johnwin and Naq Biotechnologies is U85100DL2013PTC257598. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Johnwin and Naq Biotechnologies was incorporated on 11 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Shazia Afzal was appointed as Director on 12 Jun 2019. Sadhna Yadav ceased to be Director on 11 Jun 2019. Showkat Ahmad Naqash was appointed as Director on 11 Sep 2013.
Yes, Johnwin and Naq Biotechnologies is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0034198).
The registered office of Johnwin and Naq Biotechnologies is at Shop No. 283 Second Floor Vardhman Crown Mall Plot No.2 Sector – 19 Dwarka, New Delhi, Delhi, India – 110075.
Johnwin and Naq Biotechnologies operates in the agriculture industry, in the agricultural support services segment.
The compliance status of Johnwin and Naq Biotechnologies is compliant as of 01 September 2026. The company is actively filing with the Registrar of Companies.

